Hoffman Michael B insider trades
Hoffman Michael B has filed 20 Form 4s with the SEC that we hold, for Annovis Bio, Inc. (ANVS) (Director) and Translational Development Acquisition Corp. (TDAC) (Chairman and CEO, Director). Across all of them we count 18 purchases worth $4.3M and 0 sales worth $0 reported on Form 4. In the last 12 months: 18 purchases ($4.3M) and 0 sales ($0). The largest single trade was a purchase of 975,610 shares of Annovis Bio, Inc. worth $2.0M, dated 2025-10-28. The first filing on our record is dated 2021-07-09 and the latest 2026-05-29.
Annovis Bio, Inc. (ANVS)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-10-28 | P, purchase reported on Form 4 | 975,610 | $2.0M | 2025-11-12 |
| 2025-11-14 | P, purchase reported on Form 4 | 15,000 | $31.6K | 2025-11-18 |
| 2025-11-21 | P, purchase reported on Form 4 | 10,000 | $34.9K | 2025-11-21 |
| 2025-11-21 | P, purchase reported on Form 4 | 10,000 | $35.0K | 2025-11-21 |
| 2025-11-24 | P, purchase reported on Form 4 | 1,489 | $6.1K | 2025-11-25 |
| 2025-11-24 | P, purchase reported on Form 4 | 28,096 | $116.6K | 2025-11-25 |
| 2025-11-24 | P, purchase reported on Form 4 | 415 | $1.7K | 2025-11-25 |
| 2025-11-24 | P, purchase reported on Form 4 | 9,200 | $35.4K | 2025-11-25 |
| 2025-11-24 | P, purchase reported on Form 4 | 28,096 | $116.6K | 2025-11-25 |
| 2025-11-24 | P, purchase reported on Form 4 | 415 | $1.7K | 2025-11-25 |
| 2025-11-24 | P, purchase reported on Form 4 | 9,200 | $35.4K | 2025-11-25 |
| 2025-11-24 | P, purchase reported on Form 4 | 1,489 | $6.1K | 2025-11-25 |
| 2025-12-08 | P, purchase reported on Form 4 | 15,000 | $63.6K | 2025-12-08 |
| 2025-12-08 | P, purchase reported on Form 4 | 30,000 | $130.2K | 2025-12-08 |
| 2026-04-02 | P, purchase reported on Form 4 | 713,800 | $1.5M | 2026-04-03 |
| 2026-05-20 | P, purchase reported on Form 4 | 54,933 | $104.4K | 2026-05-21 |
| 2026-05-20 | P, purchase reported on Form 4 | 2,562 | $4.5K | 2026-05-21 |
| 2026-05-20 | P, purchase reported on Form 4 | 18,849 | $33.9K | 2026-05-21 |
Translational Development Acquisition Corp. (TDAC)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1290208) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms